Brand-name drug group accepts Teva, a maker of generics - The Boston Globe
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst | Fierce Pharma
Israel's Teva seeks to acquire drug manufacturer Mylan for $40 billion - The 5 Towns Jewish Times
Analysts Split Over Buffett's Backing of Teva Pharma | BioSpace
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical | $TEVA Stock | Shares Rally After Winning FDA Approval for Migraine Therapy - Warrior Trading News
Teva must face government's kickback claims over Copaxone - judge | Reuters
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharma opens $110M plant in Hungary | Fierce Pharma
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Pharmaceuticals - Wikiwand
Teva knocked as competition fears grow for MS drug | Financial Times
Anything but Generic: A map for Selling to Teva Pharmaceuticals
